VIP (Vasoactive Intestinal Peptide) is explored for systemic and neuroinflammatory concerns
Ongoing monitoring should include assessment of weight trends, OSA symptoms, cardiovascular risk factors, and medication adherence at regular intervals, typically every 3-6 months after stabilization
Third, in patients with renal impairment, magnesium supplementation carries a risk of hypermagnesemia, as the kidneys are the primary route of magnesium excretion
However, it is important to note that oral semaglutide may not be suitable for individuals with type 1 diabetes, diabetic ketoacidosis, or certain other chronic conditions
Others may struggle with meal planning and preparation when food doesn't taste appealing, requiring additional support and strategies